⏳ Fetching live dividend data...
Home › Calculator › GLPG Dividend Calculator 2026
Galapagos N.V. · NASDAQ
Price: $27.98 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in GLPG → $10.99M in 10 years · $63.92/month
Galapagos NV functions as an integrated biopharmaceutical enterprise, concentrating its efforts on identifying, developing, and marketing a diverse range of medications aimed at critical unaddressed medical conditions. The company's comprehensive pipeline includes several significant experimental therapies. Leading this portfolio is filgotinib, a JAK1 inhibitor that is currently progressing through various clinical trial phases for the management of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel Crohn's disease, fistulizing Crohn's disease, ankylosing spondylitis, psoriatic arthritis, and uveitis. Additionally, their developmental assets feature GLPG1972, which has successfully completed its Phase 2b trial for osteoarthritis. A series of "Toledo" compounds, namely GLPG3970, GLPG4399, and GLPG4876, are in development for inflammatory conditions. GLPG4716 and Ziritaxestat are also part of the pipeline, targeting idiopathic pulmonary fibrosis. Further pipeline advancements include GLPG2737, a cystic fibrosis transmembrane conductance regulator undergoing Phase 2 clinical trials for patients afflicted with autosomal dominant polycystic kidney disease. Another JAK1 inhibitor, GLPG0555, is in Phase 1b development for osteoarthritis. Galapagos NV has established collaborative agreements with major industry players such as Gilead Sciences, Inc., AbbVie S.à r.l., and Novartis Pharma AG. The company was established in 1999 and its headquarters are located in Mechelen, Belgium.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GLPG position with:
Real after-tax yield depends on where you live and how you hold GLPG.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 7.15% | 4.35% | $715 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 6.08% | 3.28% | $608 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 5.72% | 2.92% | $572 / yr |
| 🇬🇧 UK ISA | 0% | 7.15% | 4.35% | $715 / yr |
| 🇬🇧 UK Taxable | 8.75% | 6.52% | 3.72% | $652 / yr |
| 🇨🇦 TFSA | 0% | 7.15% | 4.35% | $715 / yr |
| 🇨🇦 CA Taxable | 25% | 5.36% | 2.56% | $536 / yr |
| 🇦🇺 Super (pension) | 15% | 6.08% | 3.28% | $608 / yr |
| 🇦🇺 AU Taxable | 30% | 5.00% | 2.21% | $501 / yr |
| 🇩🇪 DE Taxable | 26.375% | 5.26% | 2.46% | $526 / yr |
| 🇫🇷 FR Taxable | 30% | 5.00% | 2.21% | $501 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
GLPG pays quarterly — 4 times per year. Next ex-div: TBD.
How GLPG compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GLPG sourced from FMP /financial-growth endpoint — real data, not estimates.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GLPG dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →